THE V122I MUTATION IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IS SIGNIFICANTLY ASSOCIATED WITH AN INCREASED INCIDENCE OF POLYNEUROPATHY

被引：0
|
作者：
Parker, Margaret
Damrauer, Scott
Erbe, David
Aldinc, Emre
Ticau, Simina
Flynn-Caroll, Alexander
Deaton, Aimee
Ward, Lucas
Rader, Daniel
Fitzgerald, Kevin
Vaishnaw, Akshay
Hinkle, Gregory
Nioi, Paul
机构：
来源：
MUSCLE & NERVE | 2020年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
198
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [11] Phenotypically Sex Differences in Transthyretin Amyloidosis V122I Mutation Patients
    Kalinoski-Dubose, Victoria
    LoRusso, Samantha
    Efebera, Yvonne
    Parikh, Samir
    Almaani, Salem
    Sharma, Nidhi
    Redder, Elyse
    Freimer, Miriam
    Bumma, Naresh
    Kahwash, Rami
    Vallakati, Ajay
    Campbell, Courtney
    CIRCULATION, 2020, 142
  • [12] Neurological onset in patients with V122I hereditary transthyretin amyloidosis: a glitch in the paradigm
    Francesca Vitali
    Maria A. Sciarrone
    Angela Romano
    Valeria Guglielmino
    Marco Luigetti
    Neurological Sciences, 2023, 44 : 4569 - 4571
  • [13] Neurological onset in patients with V122I hereditary transthyretin amyloidosis: a glitch in the paradigm
    Vitali, Francesca
    Sciarrone, Maria A.
    Romano, Angela
    Guglielmino, Valeria
    Luigetti, Marco
    NEUROLOGICAL SCIENCES, 2023, 44 (12) : 4569 - 4571
  • [14] Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program
    Trachtenberg, Barry H.
    Shah, Sachin K.
    Nussbaum, Robert L.
    Bristow, Sara L.
    Malladi, Ruthvik
    Vatta, Matteo
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (05): : E003466
  • [15] Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
    Gertz, Morie A.
    Scheinberg, Morton
    Waddington-Cruz, Marcia
    Heitner, Stephen B.
    Karam, Chafic
    Drachman, Brian
    Khella, Sami
    Whelan, Carol
    Obici, Laura
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 701 - 711
  • [16] A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Abraham, Israel Charles
    Omoworare, Oluwatobi
    Olatunji, Doyin
    Ezeano, Chimezirim
    Emmanuel Adeoba, Babawale
    Stanley, Anthony Chidera
    Oluwatobiloba, Awoyinfa Michael
    Oluwademilade, Omidiran Basit
    Shimelis, Kale Mekoya
    Olanisa, Olawale
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (26) : e38767
  • [17] NEUROPATHY IN V122I HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: A BRAZILIAN MULTICENTER CROSS-SECTIONAL STUDY
    Covaleski, Anna Paula
    Moreira, Carolina
    Costa, Marcela
    Santos, Diogo
    Franca Junior, Marcondes
    Batista, Jemima Silva
    Nascimento, Osvaldo
    Cavalcanti, Eduardo
    Nunes, Renan
    Rodrigues, Cleonisio
    Brito, Lara
    Chaves, Andrea
    Marrone, Carlo
    Kerstenetzky, Marcelo
    Marques Junior, Wilson
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S139 - S139
  • [18] Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant
    Nehashi, Takeshi
    Oikawa, Masayoshi
    Amami, Kazuaki
    Kanno, Yuki
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Yamada, Shinya
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Ishida, Takafumi
    Takeishi, Yasuchika
    INTERNATIONAL HEART JOURNAL, 2019, 60 (06) : 1441 - 1443
  • [19] Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Garcia-Pavia, Pablo
    Grogan, Martha
    Kale, Parag
    Berk, John L.
    Maurer, Mathew S.
    Conceicao, Isabel
    Di Carli, Marcelo
    Solomon, Scott D.
    Chen, Chongshu
    Yureneva, Elena
    Vest, John
    Gillmore, Julian D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 397 - 410
  • [20] Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
    Dixon, Stacy
    Kang, Xuan
    Quan, Dianna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 973 - 981
12345